$AUBN

AUBURN NATIONAL BANCORPORATION, INC (AUBN): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

AUBURN NATIONAL BANCORPORATION, INC (AUBN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K AUBURN NATIONAL BANCORPORATION, INC false 0000750574 0000750574 2026-06-05 2026-06-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: June 5,

Original reporting
Published Jun 5, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 8:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$AUBN
Neutral
high confidence
Mentioned
$AUBN
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AUBNNeutralLow
01

Why it matters

The disclosure clarifies vesting (33%/33%/34% over three years), dividend equivalents, and acceleration/forfeiture triggers (death/disability, retirement pro rata, termination without cause, change-in-control non-assumption).

02

Market read

Primarily governance/compensation mechanics; no new operating or financial catalyst is disclosed.

03

What to watch

Traders may still monitor for any concurrent director/officer changes or material amendments, but this 8-K text only describes RSU award terms.

Relevance 6/10Novelty 3/10Timing: Filed June 5, 2026 (after market)

Background

The company filed an SEC Form 8-K under Item 5.02 describing director/officer-related compensatory arrangements via RSU grants.

Company-level read

Ticker impact

$AUBNNeutralHigh confidence
Context

Auburn National Bancorporation’s Compensation Committee approved RSU grants of 4,475 shares to its three named executive officers, with 3-year vesting terms.

Expected impact

Low likelihood of sustained price repricing; any reaction should be muted and short-lived.

Evidence & confidence

The filing details RSU award mechanics (vesting schedule, dividend equivalents, restrictive covenants) without new earnings, credit, capital, or regulatory information.

Market effects

Bank equity-compensation disclosures are common and generally do not signal sector-level risk changes.

No specific regional credit, funding, or regulatory development is disclosed.

No cross-border or macro linkage is provided.

Counterpoint

If the RSU grant is unusually large relative to prior years (not provided here), it could hint at retention strategy; however, the article provides no comparative context.

Key entities

  • Auburn National Bancorporation, Inc.

    Nasdaq-listed bank that granted RSUs to three named executive officers under its 2024 Equity and Incentive Compensation Plan.

  • Compensation Committee

    Adopted and approved the June 5, 2026 RSU grants and related award agreement terms.

  • David A. Hedges

    President and CEO; one of the named executive officers receiving RSUs (2,078).

Related articles

$AUBNMed

AUBURN NATIONAL BANCORPORATION, INC (AUBN): Results of Operations and Financial Condition

AUBURN NATIONAL BANCORPORATION, INC (AUBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d183013dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 For additional information, contact: David A. Hedges President and CEO (334) 821-9200 Press Release – July 28, 2026 Auburn National Bancorporation, Inc. Reports Second Quarter Net Earnings Second Quarter 2026 vs. Second Qua

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.